ContractClinical Trial Research Agreement • October 18th, 2018
CLINICAL TRIAL RESEARCH AGREEMENT(For Use in the Czech Republic only in conjunction with Principal Investigator Contract for Work) This Agreement is entered into as of the last date on the signature page hereof, by and between Krajská nemocnice T. Bati, a. s., Havlíčkovo nábřeží 600, 76275 Zlín, Czech Republic, IČ: 27661989, DIČ: CZ27661989registered in the Companies Register maintained by the Regional Court in Brno (Section B, File No. 4437), bank details ČSOB pobočka RCB Olomouc, Jeremenkova 42, 772 00 Olomouc, account number 151203067/0300, represented by MUDr. Radomír Maráček, chairman of the board and Ing.Vlastimil Vajdák, member of the board (hereinafter called "Institution") and MERCK SHARP & DOHME, s.r.o., with its address at Na Valentince 3336/4, Smíchov, 150 00 Praha 5, Czech Republic, ID: 28462564, tax ID: CZ 28462564, registered in the Companies Register maintained by the Municipal Court in Prague (Section C, File No. 143294), autorized representative Stefano Santangelo, Ex
CLINICAL TRIAL RESEARCH AGREEMENTClinical Trial Research Agreement • July 19th, 2017
Sokolská 581, Hradec Králové-Nový Hradec Králové, zipcode 500 05 company ID: 00179906, Tax ID: CZ 00179906 bank details: Česká národní banka, account number: 24639511/0710, variable symbol: the number of invoice , represented by Prof. MUDr. Vladimír Palička,
ContractClinical Trial Research Agreement • December 1st, 2017
CLINICAL TRIAL RESEARCH AGREEMENT(For Use in the Czech Republic with a CRO) This Agreement is entered into as of the last date on the signature page hereof, by and between Health Care Service Provider THOMAYEROVA NEMOCNICE, Vídeňská 800, 140 59 Praha 4, Czech Republic, ID 00064190, VAT ID: CZ00064190, StateContribution Organization set up by the Ministry of Health of the Czech Republic, Full Text of the Foulding File No. MZDR 17268-IV/2012, registered in the Commercial Register kept by the Municipal Court in Prague, section Pr, file 1043 bank details Česká národní banka, account number XXX, represented by doc. MUDr. Zdeněk Beneš, CSc., director(hereinafter called "Provider) andCOVANCE, INC. 206 Carnegie Center Princeton NJ, 08540 USA hereinafter called "CRO" whom MERCK SHARP & DOHME CORP. with its address at 1 Merck Drive, Whitehouse Station, New Jersey 08889 USA, hereinafter called "Sponsor" has contractually engaged as a contract research organization concerning the management, fundi
ContractClinical Trial Research Agreement • January 6th, 2017
CLINICAL TRIAL RESEARCH AGREEMENT(For Use in the Czech Republic) This Agreement is entered into as of the last date on the signature page hereof, by and between FAKULTNÍ NEMOCNICE PLZEŇ, Edvarda Beneše 1128/13,Plzeň Zip code: 305 99, company Id. 00669806, Tax ID: CZ00669806, XXX, represented by MUDr. Václav Šimánek, Ph.D., executive director (hereinafter called "Provider of Medical Services") and MERCK SHARP & DOHME, s.r.o., with its address at Evropská 2588/33a, Prague 6, ZIP code 160 00, ID: 284 62564, tax ID: CZ 284 62 564, registered in the Companies Register maintained by the Municipal Court in Prague (Section C, File No. 143297), autorized representative Piotr Miekus, Executive Director, acting in its own name at the request of Merck Sharp & Dohme Corp. with its address at 1 Merck Drive, Whitehouse Station, New Jersey 08889, United States of America (hereinafter called "Sponsor") and XXX (hereinafter called “Principal Investigator”). SMLOUVA O PROVEDENÍ KLINICKÉHO HODNOCENÍ(Pro p
ContractClinical Trial Research Agreement • September 26th, 2017
CLINICAL TRIAL RESEARCH AGREEMENT (For Use in the Czech Republic only in conjunction with Principal Investigator Contract for Work) This Agreement is entered into as of the last date on the signature page hereof, by and between FAKULTNÍ NEMOCNICE V MOTOLE, state contributory organization, with its address at V Úvalu 84, Prague 5, Zip code: 150 06, company ID: 00064203, Tax ID: CZ00064203, represented by XXX under a mandate dated 29 November 2016 (hereinafter called "Medical service provider") and Merck Sharp & Dohme, s.r.o., with its address at Evropská 2588/33a, Prague 6, ZIP code 160 00, ID: 284 62 564, tax ID: CZ 284 62 564, registered in the Companies Register maintained by the Municipal Court in Prague (Section C, File No. 143294), represented by Renan Özyerli, Managing Director, acting in its own name at the request of Merck Sharp & Dohme Corp. with its address at One Merck Drive, Whitehouse Station, New Jersey 08889, USA (hereinafter called "Sponsor"). SMLOUVA O PR
CLINICAL TRIAL RESEARCH AGREEMENT SMLOUVA O PROVEDENÍ KLINICKÉHO HODNOCENÍClinical Trial Research Agreement • April 5th, 2022
ContractClinical Trial Research Agreement • February 2nd, 2018
CLINICAL TRIAL RESEARCH AGREEMENT SMLOUVA O PROVEDENÍ KLINICKÉHO HODNOCENÍ This Clinical Trial Research Agreement (“Agreement”) is entered into as of 25 January 2018 and shall become effective upon the publishing of this executed Agreement in the Agreement Registry (“Effective Date”), by and among University Hospital Ostrava, with a place of business at 17. Listopadu 1790/5, 708 52 Ostrava-Poruba, Czech Republic, ID Number: 00843989, VAT Number: CZ00843989, TheFoundantion deed from 25th of November 1990, ref. OP- 054-25.11.90, In matters of this Agreement is authorized to act and sign: Josef Srovnal, M.D., deputy director for medical care, hereinafter called (“Institution”) and Prof. MUDr. Roman Hájek, CSc, with a place of business at University Hospital Ostrava, Hematooncology Clinic, 17.listopadu 1790, 708 52 Ostrava-Poruba, Czech Republic, hereinafter called (“Principal Investigator”) and Acerta Pharma B.V., with registered office at xxxxxxx, a Dutch limited liability company, rep
ContractClinical Trial Research Agreement • May 9th, 2017
CLINICAL TRIAL RESEARCH AGREEMENT (For Use in the Czech Republic only in conjunction with Principal Investigator Contract for Work) This Agreement is entered into as of the last date on the signature page hereof, by and between FAKULTNÍ NEMOCNICE OLOMOUC, with address at I.P. Pavlova 185/6, Olomouc, Zip code 779 00, Czech Republic, company ID: 00098892, Tax ID: CZ00098892, bank details Česká národní banka, account number 36334811/0710, represented by Doc. MUDr. Roman Havlík, Ph.D., Director (hereinafter called "Institution") and MERCK SHARP & DOHME, s.r.o., with its address at Evropská 2588/33a, Prague 6, Zip code 160 00, ID: 284 62 564, tax ID: CZ 284 62 564, registered in the Companies Register maintained by the Municipal Court in Prague (Section C, File No. 143294), bank details: CityBank Europe, plc. account number: 2051460102/2600 acting in its own name at the request of MERCK SHARP & DOHME CORP. with its address at 1 Merck Drive, Whitehouse Station, New Jersey 08889, Un
ContractClinical Trial Research Agreement • December 8th, 2016
CLINICAL TRIAL RESEARCH AGREEMENT(For Use in the Czech Republic) This Agreement is entered into as of the last date on the signature page hereof, by and between INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE, Vídeňská 1958/9, Zipcode: 140 21, Prague 4, Czech Republic, company ID: 00023001, Tax ID: CZ00023001 , bank details: represented by MUDr. Aleš Herman, Ph.D., director (hereinafter called "Institution") and Merck Sharp & Dohme, s.r.o., with its address at Evropská 2588/33a, Prague 6, ZIP code 160 00, ID: 28462 564, tax ID: CZ 284 62 564, registered in the Companies Register maintained by the Municipal Court in Prague (Section C, File No. 143294), acting in its own name at the request of Merck Sharp & Dohme Corp. with its address at One Merck Drive, Whitehouse Station, New Jersey 08889, USAAnd XXX(hereinafter called “Principal Investigator”) S MLOUVA O PROVEDENÍ K LINICKÉHO HODNOCENÍ(Pro použití v České republice) Tato smlouva je uzavřena ke dni, jehož datum je uvedeno jako pozděj
Amendment to Clinical Trial Research Agreement (“Amendment”)Clinical Trial Research Agreement • May 25th, 2016
The Parties entered into a Clinical Trial Research Agreement, dated [insert effective date] in relation to clinical study, [insert study title and Protocol No.] (“Agreement”)
CLINICAL TRIAL RESEARCH AGREEMENT No. __________Clinical Trial Research Agreement • July 15th, 2009
This Agreement is entered into by and between the University of Texas ____________________ hereinafter called "Institution," and ____________________a corporation with its principle office and place of business at, _______________, hereinafter called "Sponsor."
ContractClinical Trial Research Agreement • November 15th, 2017
CLINICAL TRIAL RESEARCH AGREEMENT SMLOUVA O PROVEDENÍ KLINICKÉHO HODNOCENÍ This Clinical Trial Research Agreement (“Agreement”) is entered into as of the publishing of this executed Agreement in Agreement Registry (“Effective Date”), by and among Fakultní nemocnice Hradec Králové , Sokolská 581, 500 05 Hradec Králové – Nový Hradec Králové, Czech Republic, DIČ: CZ00179906, represented by prof. MUDr. Vladimír Palička, CSc., dr.h.c., Director, (hereinafter called “Provider”) and , (hereinafter called “Principal Investigator”) and Acerta Pharma B.V., with registered office at a Dutch limited liability company, represented by duly authorized representative(s) of Acerta Pharma B.V., (“Sponsor”). The Provider, Principal Investigator and Sponsor are hereinafter individually referred to as a (“Party”) and are collectively known as the (“Parties”). Tuto smlouvu o provedení klinického hodnocení (dále jen„smlouva“) mezi sebouke dni uvešejnení podepsané smlouvy v Registru smluv (dále jen „datum
CLINICAL TRIAL RESEARCH AGREEMENTClinical Trial Research Agreement • August 23rd, 2018 • Lixte Biotechnology Holdings, Inc. • Pharmaceutical preparations
This CLINICAL TRIAL RESEARCH AGREEMENT (this “AGREEMENT”) is entered into on August 20, 2018 (the “Effective Date”), by and between H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc., with a primary location at 12902 Magnolia Drive, Tampa, FL 33612-9497, hereinafter called “INSTITUTION,” and Lixte Biotechnology Holdings, Inc., with its office and place of business at 248 Route 25A, No. 2, East Setauket, NY, hereinafter called “LIXTE.” (“INSTITUTION” and “LIXTE”, each referred to as a “Party” and together, “Parties”)
ContractClinical Trial Research Agreement • February 12th, 2019
CLINICAL TRIAL RESEARCH AGREEMENT SMLOUVA O PROVEDENÍ VÝZKUMNÉHO KLINICKÉHO HODNOCENÍ This Clinical Trial Research Agreement(“Agreement”) is dated as of defined in Section 11.1 of this Agreement (“Effective Date”) by and among CSL Behring GmbH having its principal place of business atEmil-von-Behring-Str. 76, 35041, Marburg, Germany (“Sponsor”), and Fakultní nemocniceMotol having its principal place of business address at V Úvalu 84, 150 06 Praha 5, Czech Republic (“Service Provider”); collectively referred to as “the parties.” Tato smlouva o provedení výzkumného klinického hodnocení(dále jen„smlouva“) vstoupí v účinnost, jak je definováno v článku 11.1 v této smlouvě (dále jen „datum účinnosti“), a je uzavírána mezi společností CSL Behring GmbH se sídlem na adrese Emil-von-Behring-Str. 76, 35041 Marburg, Německo (dále jen „zadavatel“) a Fakultní nemocnicí Motol se sídlem na adrese V Úvalu 84, 150 06 Praha 5, Česká republika (dále jen „ poskytovatel služeb“); dále společně označováni j
CLINICAL TRIAL RESEARCH AGREEMENTClinical Trial Research Agreement • February 1st, 2023
564, tax ID: CZ 284 62 564, registered in the Companies Register maintained by the Municipal Court in Prague (Section C, File No. 143294), acting in its own name at the request of Merck Sharp & Dohme Corp., with its address at One Merck Drive, Whitehouse Station, New Jersey 08889 USA (hereinafter the "Sponsor").
CLINICAL TRIAL RESEARCH AGREEMENTClinical Trial Research Agreement • July 15th, 2009 • Texas
This Agreement is entered into this ____ day of ______, 1993, by and between The University of Texas _________, hereinafter called "Institution," and SCHERING-PLOUGH RESEARCH INSTITUTE, a Delaware corporation with its office and place of business at 2015 Galloping Hill Road, Kenilworth, New Jersey 07033, hereinafter called "Sponsor."
CLINICAL TRIAL RESEARCH AGREEMENTClinical Trial Research Agreement • July 13th, 2021 • Jupiter Wellness, Inc. • Perfumes, cosmetics & other toilet preparations
This Agreement is entered into by and between: Applied Biology, s.r.o. with an address at Jaurisova 515/4, 140 00 Prague 4, Michle, hereinafter called "Institution," and Jupiter Wellness, Inc., with an address at 725 N. Highway A1A, Suite C106, Jupiter, FL 33477, hereinafter called “Sponsor."
CLINICAL TRIAL RESEARCH AGREEMENTClinical Trial Research Agreement • May 24th, 2007
INSTITUTIONName Address ABNContact for Notices Fax for Notices Phone Number SPONSORName Address ABNContact for Notices Fax for Notices Phone Number STUDY NAME PROTOCOL NUMBER DATE OF AGREEMENT
